Abstract
Radical lymphadenectomy for malignant melanoma continues to be controversial. In order to reduce morbidity but preserve prognostic informations, a minimally invasive technique for the iliac part of dissection was developed. We evaluated the practicability of this intervention under routine conditions as well as its prognostic impact. A total of 106 patients with tumor cell involvement of at least one inguinal lymph node underwent open inguinal dissection combined with a minimally invasive iliac dissection. Perioperative and postoperative data on morbidity, survival, and histopathological features of the primary and the dissected specimens were collected. Histopathological data were evaluated statistically for their prognostic relevance. Of the 106 patients, 38 showed evidence of additional metastases in the resected specimen, of which 11 cases were related to the iliac portion. Detection of lymph node metastases in the specimen was significantly correlated with a poorer prognosis, while out of all factors implicated, a new prognostic factor comprising iliac tumor involvement and primary tumor ulceration showed the strongest statistical correlation with prognosis. The median dissection time was 137 min, 58 min devoted to the iliac part. Complications necessitating reoperation (n = 7) related only to the inguinal wound area. Minimally invasive iliac lymph node dissection is ready for clinical routine. The additional information obtained by the iliac dissection—in particular, in combination with primary tumor ulceration—is of important prognostic relevance. Further development of this technique performing a completely minimally invasive ilioinguinal dissection may confer additional advantages.
Similar content being viewed by others
References
Garbe C, Leiter U (2009) Melanoma epidemiology and trends. Clinics in dermatology 27(1):3–9
Essner R, Scheri R, Kavanagh M, Torisu-Itakura H, Wanek LA, Morton DL (2006) Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. Arch Surg 141(9):877–882, discussion 882-874
Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R (2008) Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res 18(1):61–67
Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ (2006) Sentinel-node biopsy or nodal observation in melanoma. The New England journal of medicine 355(13):1307–1317
Sabel MS, Griffith KA, Arora A, Shargorodsky J, Blazer DG 3rd, Rees R, Wong SL, Cimmino VM, Chang AE (2007) Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery 141(6):728–735
Kettlewell S, Moyes C, Bray C, Soutar D, MacKay A, Byrne D, Shoaib T, Majumder B, MacKie R (2006) Value of sentinel node status as a prognostic factor in melanoma: prospective observational study. BMJ (Clinical research ed 332 (7555):1423
Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL (2004) Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol 22(18):3677–3684
Santinami M, Carbone A, Crippa F, Maurichi A, Pellitteri C, Ruggeri R, Zoras O, Patuzzo R (2009) Radical dissection after positive groin sentinel biopsy in melanoma patients: rate of further positive nodes. Melanoma Res 19(2):112–118
Wong SL, Morton DL, Thompson JF, Gershenwald JE, Leong SP, Reintgen DS, Gutman H, Sabel MS, Carlson GW, McMasters KM, Tyler DS, Goydos JS, Eggermont AM, Nieweg OE, Cosimi AB, Riker AI DGC (2006) Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Annals of surgical oncology 13(6):809–816
Guggenheim M, Dummer R, Jung FJ, Mihic-Probst D, Steinert H, Rousson V, French LE, Giovanoli P (2008) The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma—a retrospective analysis of 392 cases. British journal of cancer 98(12):1922–1928
Satzger I, Meier A, Hoy L, Volker B, Kapp A, Hauschild A, Gutzmer R Sentinel node dissection delays recurrence and prolongs melanoma-related survival: an analysis of 673 patients from a single center with long-term follow-up. Annals of surgical oncology
Spillane AJ, Winstanley J, Thompson JF (2009) Lymph node ratio in melanoma: a marker of variation in surgical quality? Cancer 115(11):2384–2387
Amersi F, Morton DL (2007) The role of sentinel lymph node biopsy in the management of melanoma. Advances in surgery 41:241–256
Badgwell B, Xing Y, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN (2007) Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Annals of surgical oncology 14(10):2867–2875
Hughes TM, A'Hern RP, Thomas JM (2000) Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. The British journal of surgery 87(7):892–901
Hughes TM, Thomas JM (1999) Combined inguinal and pelvic lymph node dissection for stage III melanoma. The British journal of surgery 86(12):1493–1498
Schneider C, Brodersen JP, Scheuerlein H, Tamme C, Lippert H, Kockerling F (2003) Combined endoscopic and open inguinal dissection for malignant melanoma. Langenbeck's archives of surgery/Deutsche Gesellschaft fur Chirurgie 388(1):42–47
Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19(16):3635–3648
Kaufmann R, Tilgen W, Garbe C (1998) Malignant melanoma. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 48(1):S30–38
Wittekind C MH (2010) Malignes Melanom der Haut. In: TNM: Klassifikation maligner Tumoren, vol 7. Wiley-VCH Verlag GmbH&KGaATNM: Klassifikation maligner Tumoren, pp 161-165
Shen P, Conforti AM, Essner R, Cochran AJ, Turner RR, Morton DL (2000) Is the node of Cloquet the sentinel node for the iliac/obturator node group? Cancer journal (Sudbury. Mass 6(2):93–97
Strobbe LJ, Jonk A, Hart AA, Peterse JL, Wobbes T, Nieweg OE, Kroon BB (2001) The value of Cloquet's node in predicting melanoma nodal metastases in the pelvic lymph node basin. Annals of surgical oncology 8(3):209–214
Guggenheim MM, Hug U, Jung FJ, Rousson V, Aust MC, Calcagni M, Kunzi W, Giovanoli P (2008) Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Annals of surgery 247(4):687–693
Ali-Khan AS, Crundwell M, Stone C (2008) Inguinal lymphadenectomy combined with staging endoscopic pelvic node sampling for stage III melanoma. J Plast Reconstr Aesthet Surg
Jones WO, Cable RL, Gilling PJ (1995) Laparoscopic pelvic lymphadenectomy for malignant melanoma. The Australian and New Zealand journal of surgery 65(10):765–767
Picciotto F, Volpi E, Zaccagna A, Siatis D (2003) Transperitoneal laparoscopical iliac lymphadenectomy for treatment of malignant melanoma. Surgical endoscopy 17(10):1536–1540
Trias M, Targarona EM, Piulachs J, Balague C, Bombuy E, Espert JJ, Moral A, Castel MT (1998) Extraperitoneal laparoscopically assisted ilioinguinal lymphadenectomy for treatment of malignant melanoma. Arch Surg 133(3):272–274, discussion 275
Conflicts of interest
All authors disclose any financial and personal relationships with other people or organizations that could have inappropriately influenced their work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ising, I.M., Bembenek, A., Gutzmer, R. et al. Enhanced postoperative lymphatic staging of malignant melanoma by endoscopically assisted iliacoinguinal dissection. Langenbecks Arch Surg 397, 429–436 (2012). https://doi.org/10.1007/s00423-011-0888-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-011-0888-2